Which sedation is safer for stroke patients during clot removal?
NCT ID NCT06139692
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two different ways to keep patients comfortable and calm during a procedure to remove a blood clot from the brain after a stroke. The goal is to find out which method helps patients recover better and have fewer problems. About 810 adults having this emergency treatment will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 810 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2023
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥18 years 2. Presenting with symptoms of acute ischemic stroke 3. CTA or MRA confirmed occlusion of the anterior circulation (intracranial carotid artery or M1, M2 segment of the middle cerebral artery) 4. Randomization finished within 24 hours of symptom onset or time last know well 5. Pre-stroke mRS score ≤2 6. NIHSS score ≥6 at the time of randomization 7. ASPECTS value ≥3 8. Informed consent signed Exclusion Criteria: General exclusion criteria 1. Pregnant or lactating women 2. Known allergy to contrast agents or nitinol devices 3. Known allergy to midazolam or other benzodiazepines 4. Known allergy to dexmedetomidine or its components 5. Planned to receive general anesthesia for EVT 6. Uncontrolled hypertension or hypotension (defined as systolic blood pressure \>185 mmHg or \< 90 mmHg, diastolic blood pressure \>110 mmHg or \< 60 mmHg) 7. Second-degree or third-degree heart blockage or bradyarrhythmia with a baseline heart rate lower than 50 beats/min 8. Any major surgery or serious trauma within 14 days 9. Known genetic or acquired bleeding diathesis (platelet count \< 100\\\*109 /L, activated partial thromboplastin time \> 50 s or international normalized ratio \> 1.7) 10. Blood glucose \<2.8 or \> 22.2 mmol/L 11. Severe renal insufficiency (defined as glomerular filtration rate \<30 ml/min or serum creatinine \>220 mmol/L (2.5mg/dl)) 12. Receiving hemodialysis or peritoneal dialysis 13. Life expectancy less than 1 year 14. Severe agitation or seizures 15. Clinical manifestations of central nervous system vasculitis 16. Premorbid neurological disease or mental disorders confounding evaluation 17. Unwilling to be followed up within 90 days 18. Participation in other interventional randomized clinical trials Imaging exclusion criteria 1\. Evidence of intracranial hemorrhage on CT or MRI 2. Cerebellar infarction with obvious space-occupying effects and fourth ventricle compression on CT or MRI 3. Any untreated or incompletely treated intracranial aneurysm or any intracranial vascular malformation 4. Bilateral occlusion or multiple intracranial vessels occlusions 5. Intracranial tumors (with mass effect)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute ischemic stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Jinling Hospital, Medical School of Nanjing University
RECRUITINGNanjing, None Selected, China
-
The General Hospital of Western Theater Command PLA
RECRUITINGChengdu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can PET scans reveal hidden heart inflammation after a stroke?
- Can an implanted heart monitor catch hidden irregular heartbeats after stroke?
- China builds national watchdog for brain blood vessel devices
- Can tiny neural exosomes help the brain heal after a severe stroke?
- Can a new antibody boost recovery after severe stroke?
- After stroke, a balloon or a stent? trial tests which rescue opens blocked brain arteries better